期刊文献+

重症药疹26例临床分析及护理 被引量:4

下载PDF
导出
摘要 目的:探讨早期大剂量使用糖皮质激素治疗重症药疹的临床疗效及护理措施。方法:对26例重症药疹患者早期给予甲强龙80~100 mg/d治疗,病情控制后逐渐减量直至停药。同时给予皮肤、口腔黏膜、会阴及眼部等一般护理,并给予健康指导。结果:大量糖皮质激素治疗10 d后病情基本控制、皮疹全部消退,激素用量减至40 mg/d,并逐渐减量直至停药,26例均痊愈出院。结论:早期大剂量使用糖皮质激素治疗重症药疹的临床疗效显著,对重型药疹患者实施皮损护理、换药及支持疗法等护理干预措施可减少并发症的发生,有助于患者早期康复。
作者 唐晓兰
出处 《齐鲁护理杂志(上旬刊)》 2012年第1期68-69,共2页 Journal of Qilu Nursing
  • 相关文献

参考文献2

二级参考文献28

  • 1Enomoto M, Ochi M, Teramae K, et al. Codeine phosphate-induced hypersensitivity syndrome. Ann Pharmacother, 2004, 38: 799-802.
  • 2Mitani N, Aihara M, Yamakawa Y, et al. Drug-induced hypersensitivity syndrome due to cyanamide associated with multiple reactivation of human herpesviruses. J Med Virol, 2005, 75: 430-434.
  • 3Tohyama M, Yahata Y, Yasukawa M, et al. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol, 1998, 134:1113-1117.
  • 4Suzuki Y, Inagi R, Aono T, et al. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol, 1998, 134:1108-1112.
  • 5Aihara Y, Ito SI, Kobayashi Y, et al. Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real-time quantitative polymerase chain reaction. Br J Dermatol, 2003, 149: 165-169.
  • 6Hashimoto K, Yasukawa M, Tohyama M. Human herpesvirus 6 and drug allergy. Curt Opin Allergy Clin Immunol, 2003, 3: 255-260.
  • 7Kano Y, Inaoka M, Sakuma K, et al. Virus reactivation and intravenous immunoglobulin ( IVIG ) therapy of drug-induced hypersensitivity syndrome. Toxicology, 2005, 209: 165-167.
  • 8Ohtani T, Hiroi A, Sakurane M, et al. Slow acetylator genotypes as a possible risk factor for infectious mononucleosis-like syndrome induced by salazosulfapyfidine. Br J Dermatol, 2003, 148: 1035-1039.
  • 9Martin AM, Nolan D, Gaudieri S, et al. Pharmacogenetics of antiretroviral therapy: genetic variation of response and toxicity. Pharmacogenomics, 2004, 5: 643-655.
  • 10Mallal S, Nolan D, Witt C, et al. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet, 2002, 359:727-732.

共引文献51

同被引文献22

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部